GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company’s Vice President of Sales and Marketing..

马萨诸塞州加德纳（GARDNER），2024年7月8日（Global NEWSWIRE）--精密光学公司（NASDAQ:POCI）是医疗和国防行业先进光学仪器的领先设计师和制造商，今天宣布任命克莱·施瓦布（Clay Schwabe）为公司销售和营销副总裁。。

Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies specialist with experience in early-stage commercialization of minimally invasive surgical products and procedures.

施瓦贝先生在医疗器械市场准入、销售、销售管理、全球产品营销和商业化方面拥有超过15年的经验。他是一位新兴技术专家，在微创手术产品和程序的早期商业化方面拥有丰富经验。

Most recently, he served as VP Business Development, Commercial Strategy, CRO, and Market Access of Veranex. From 2021 to 2023, he was VP Sales / Business Development – Early Commercial and Market access for PRIA Healthcare where he built out the business development team to include sales operations, marketing, and field operations.

最近，他担任Veranex的业务发展、商业战略、CRO和市场准入副总裁。2021年至2023年，他担任PRIA Healthcare的销售/业务开发副总裁-早期商业和市场准入，在那里他建立了业务开发团队，包括销售运营、营销和现场运营。

From 2016 to 2021 he was an Area Manager with Vertiflex, which was acquired by Boston Scientific in 2019, and from 2007 to 2016 he was the marketing manager and interventional sales consultant at Medtronic. Mr. Schwabe is a graduate from the United States Military Academy at West Point having served as a United States Army Captain, Platoon Leader, Battalion Staff Officer, Army World Class Athlete Program, and holds a BS in Systems Engineering..

2016年至2021年，他担任Vertiflex的区域经理，该公司于2019年被波士顿科学公司收购，2007年至2016年，他担任美敦力的营销经理和介入销售顾问。施瓦贝先生毕业于美国西点军校，曾任美国陆军上校、排长、营参谋、陆军世界级运动员项目，并拥有系统工程学士学位。。

“We are extremely excited to welcome Clay Schwabe to the executive team at Precision Optics,” stated Dr. Joe Forkey, CEO of Precision Optics. “Clay’s entrepreneurial mindset and experience developing and executing effective strategies in high growth environments to uncover innovative solutions to complicated business challenges within the medical device industry, will serve us and our customers well going forward.”.

“我们非常高兴地欢迎克莱·施瓦布加入精密光学的执行团队，”精密光学首席执行官乔·福基博士表示。“克莱的创业心态和经验，在高增长环境中制定和执行有效战略，以发现医疗器械行业复杂业务挑战的创新解决方案，将为我们和我们的客户提供良好的发展前景。”。

The Company’s current SVP of Sales and Marketing, Jeff DiRubio, will transition out of his role as a full-time employee to a consulting role where he will continue to advise the company on product development, marketing, business development and overall strategic planning for the company.

公司目前的销售和营销高级副总裁杰夫·迪鲁比奥（Jeff DiRubio）将从全职员工转变为咨询师，他将继续为公司提供产品开发、营销、业务开发和整体战略规划方面的建议。

“I want to thank Jeff for his tremendous contribution to Precision Optics for over ten years. During this time, we have increased sales by more than 700% as we have leveraged our unique micro-optics and digital imaging capabilities to drive innovation across the medical device and aerospace/defense industries.

“我要感谢杰夫十多年来对精密光学做出的巨大贡献。在此期间，我们利用独特的微光学和数字成像能力，推动医疗器械和航空航天/国防行业的创新，销售额增长了700%以上。

I am pleased that Jeff has agreed to continue in a consulting role and look forward to Jeff’s continued contributions to the Company.”.

我很高兴杰夫同意继续担任咨询角色，并期待杰夫继续为公司做出贡献。”。

About Precision Optics Corporation

关于精密光学公司

Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company designs and manufactures next-generation product solutions for the most challenging customer requirements.

精密光学成立于1982年，是一家垂直集成光学公司，主要致力于将其专有的微光学和3D成像技术应用于医疗保健和国防/航空航天行业，提供从新产品概念到大规模制造的服务。该公司利用其领先的内部设计、原型、监管和制造能力，以及灯塔成像部门的电子成像专业知识和罗斯光学部门在全球范围内的大量采购、检查和生产资源，为最具挑战性的客户需求设计和制造下一代产品解决方案。

Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery, including single-use medical devices, as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems.

在医疗保健领域，精密光学使世界各地的下一代医疗设备公司能够满足外科界日益增长的需求，外科界需要更多增强和更小的成像系统进行微创手术，包括一次性医疗设备，以及3D内窥镜系统，以支持外科机器人系统的快速扩散。

In addition to these next generation applications, Precision Optics has supplied top tier medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power.

除了这些下一代应用之外，几十年来，精密光学为顶级医疗器械公司提供了各种各样的光学产品，包括复杂的内耦合器和专用内窥镜。该公司还利用其在微光学方面的技术熟练程度，实现需要最高质量标准和尺寸、重量和功率优化的前沿国防/航空航天应用。

For more information, please visit www.poci.com..

。。

About Forward-Looking Statements

关于前瞻性声明

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions.

本新闻稿包含前瞻性声明。前瞻性声明包括但不限于表达公司意图、信念、期望、策略、预测的声明或与公司未来活动或未来事件或条件相关的任何其他声明。

These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict.

这些报表基于当前对公司业务的预期、估计和预测，部分基于公司管理层的假设。这些声明并不能保证未来的业绩，涉及难以预测的风险、不确定性和假设。

Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous risk factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law..

因此，由于许多风险因素，实际结果和结果可能与前瞻性声明中表达或预测的结果存在重大差异。任何前瞻性声明仅在其作出之日起生效，除法律要求外，本公司不承担更新任何前瞻性声明的任何义务。。

Company Contact:

公司联系人：

PRECISION OPTICS CORPORATION

精密光学公司

22 East Broadway

东百老汇22号

Gardner, Massachusetts 01440-3338

马萨诸塞州加德纳01440-3338

Telephone: 978-630-1800

电话：978-630-1800

Investor Contact:

投资者联系人：

LYTHAM PARTNERS, LLC

LYTHAM合伙人

Robert Blum

罗伯特·布仑姆

Telephone: 602-889-9700

电话：602-889-9700

poci@lythampartners.com

poci@lythampartners.com